Laboratory Studies
- The diagnosis of nocardiosis is established with culture of the causative organism from the infection site(s). Because nocardiae grow slower than common bacteria, the microbiology laboratory should always be notified when nocardiosis is clinically suspected. This is particularly true when sputum is the submitted specimen. Respiratory secretions, skin biopsy samples, and aspirates from abscesses are the most common specimens from which Nocardia species are identified. Direct smears or histopathologic stains of these specimens can be highly suspicious, as noted above. Nocardia species can usually be isolated in 3-5 days.
- Blood cultures are positive for Nocardia organisms in a minority of patients, but they always should be obtained when pulmonary or disseminated nocardiosis is suspected.
- Immunodominant antigens of Nocardia species have been identified and used in serological assays. However, no serologic technique or molecular technique is yet available for routine clinical use. Similarly, nucleic acid amplification assays have been described but are not available for routine clinical use.
Imaging Studies
- Plain chest radiography and, often, CT chest scanning are useful in evaluating pulmonary nocardiosis and in monitoring the course of the infection. However, no characteristic radiographic findings have been described. Radiographic findings may include irregular nodules (which may cavitate), reticulonodular or diffuse alveolar pulmonary infiltrates, lung abscess formation, and pleural effusion.
Plain chest radiograph in a patient with nocardiosis. Image courtesy of Applied Radiology, Anderson Publishing, LTD. 
Chest CT scan in a patient with pleuropulmonary nocardiosis. Image courtesy of Applied Radiology, Anderson Publishing, LTD. - All patients with nocardiosis, except those with mycetoma, should undergo brain imaging with either CT scanning or MRI (likely preferred). Intracranial abscess is the most common abnormality found. Spread of intracranial abscesses to contiguous structures is particularly suggestive of nocardiosis.
Brain CT scan in a patient with nocardial brain abscess. Image courtesy of Applied Radiology, Anderson Publishing, LTD. - Localized symptoms other than pulmonary or CNS should be evaluated with appropriate site-specific imaging.
Other Tests
- If meningitis is suspected, cerebrospinal fluid (CSF) should be obtained for analysis unless this is contraindicated by mass effect on brain imaging. Nocardial meningitis typically results in findings typical of bacterial meningitis (ie, neutrophilic pleocytosis, hypoglycorrhachia, and a mildly elevated CSF protein level).
Procedures
- Biopsy of skin lesions or aspiration of deep abscesses may be required for diagnosis of nocardiosis.
- Similarly, in patients with pulmonary nocardiosis, bronchoalveolar lavage and/or transbronchial lung biopsy may be required if the microbial etiology is not definitively established based on examination and culture of expectorated sputum.
Histologic Findings
Suppurative infection with organisms of characteristic morphology and staining attributes is the typical histopathologic finding in nocardiosis. Granulomatous infection is occasionally encountered.
Sorrell TC, Mitchell DH, Iredell JR. Nocardia species. In: Mandell, Bennett, Dolin. Principles and Practice of Infectious Diseases. volume 2. 6th edition. Churchill Livingstone; 2005.
Beaman BL, Beaman L. Nocardia species: host-parasite relationships. Clin Microbiol Rev. Apr 1994;7(2):213-64. [Medline].
McNeil MM, Brown JM. The medically important aerobic actinomycetes: epidemiology and microbiology. Clin Microbiol Rev. Jul 1994;7(3):357-417. [Medline].
Smego RA Jr, Moeller MB, Gallis HA. Trimethoprim-sulfamethoxazole therapy for Nocardia infections. Arch Intern Med. Apr 1983;143(4):711-8. [Medline].
Boiron P, Locci R, Goodfellow M, et al. Nocardia, nocardiosis and mycetoma. Med Mycol. 1998;36 Suppl 1:26-37. [Medline].
Castro JG, Espinoza L. Nocardia species infections in a large county hospital in Miami: 6 years experience. J Infect. Apr 2007;54(4):358-61. [Medline].
Filice GA. Nocardiosis in persons with human immunodeficiency virus infection, transplant recipients, and large, geographically defined populations. J Lab Clin Med. Mar 2005;145(3):156-62. [Medline].
Hui CH, Au VW, Rowland K, et al. Pulmonary nocardiosis re-visited: experience of 35 patients at diagnosis. Respir Med. Jun 2003;97(6):709-17. [Medline].
Kilincer C, Hamamcioglu MK, Simsek O, et al. Nocardial brain abscess: review of clinical management. J Clin Neurosci. May 2006;13(4):481-5. [Medline].
Lederman ER, Crum NF. A case series and focused review of nocardiosis: clinical and microbiologic aspects. Medicine (Baltimore). Sep 2004;83(5):300-13. [Medline].
Lerner PI. Nocardiosis. Clin Infect Dis. Jun 1996;22(6):891-903; quiz 904-5. [Medline].
Matulionyte R, Rohner P, Uckay I, et al. Secular trends of nocardia infection over 15 years in a tertiary care hospital. J Clin Pathol. Aug 2004;57(8):807-12. [Medline].
Pintado V, Gomez-Mampaso E, Cobo J, et al. Nocardial infection in patients infected with the human immunodeficiency virus. Clin Microbiol Infect. Jul 2003;9(7):716-20. [Medline].
Saubolle MA, Sussland D. Nocardiosis: review of clinical and laboratory experience. J Clin Microbiol. Oct 2003;41(10):4497-501. [Medline].
Pilsczek FH, Augenbraun M. Mycetoma fungal infection: multiple organisms as colonizers or pathogens?. Rev Soc Bras Med Trop. Jul-Aug 2007;40(4):463-5. [Medline].
Martinez Tomas R, Menendez Villanueva R, Reyes Calzada S, et al. Pulmonary nocardiosis: risk factors and outcomes. Respirology. May 2007;12(3):394-400. [Medline].
Peleg AY, Husain S, Qureshi ZA, et al. Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study. Clin Infect Dis. May 15 2007;44(10):1307-14. [Medline].
Uhde KB, Pathak S, McCullum I Jr, Jannat-Khah DP, Shadomy SV, Dykewicz CA, et al. Antimicrobial-resistant nocardia isolates, United States, 1995-2004. Clin Infect Dis. Dec 15 2010;51(12):1445-8. [Medline].
Jodlowski TZ, Melnychuk I, Conry J. Linezolid for the treatment of Nocardia spp. infections. Ann Pharmacother. Oct 2007;41(10):1694-9. [Medline].
Sridhar MS, Gopinathan U, Garg P, et al. Ocular nocardia infections with special emphasis on the cornea. Surv Ophthalmol. Mar-Apr 2001;45(5):361-78. [Medline].
| N asteroides | N farcinica | N nova | N brasiliensis | N transvalensis | N otitidiscaviarum | |
| Sulfamethoxazole | 96-99 | 89-100 | 89-97 | 99-100 | 90 | Variable |
| TMP-SMX | 100 | --- | --- | 100 | 88 | Variable |
| Amoxicillin-clavulanate | 53-67 | 47-71 | 3-6 | 65-97 | 30 | Resistant |
| Ceftriaxone | 94-100 | 0-73 | 100 | 88-100 | 50 | --- |
| Imipenem | 77-98 | 64-87 | 100 | 20-30 | 90 | Resistant |
| Amikacin | 100 | 100 | 100 | 100 | 82 | Susceptible |
| Minocycline | 78-94 | 20-96 | 89-100 | 75-90 | 54 | Susceptible |
| Linezolid | 100 | 100 | 100 | 100 | 100 | 100 |
Print
